tadalafil has been researched along with Cirrhosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Dohi, K; Hirayama, M; Ito, H; Kabwe, JC; Ko, H; Maruyama, J; Maruyama, K; Mashimo, T; Mitani, Y; Miyasaka, Y; Nishimura, Y; Ohashi, H; Okamoto, R; Oshita, H; Otsuki, S; Oya, K; Sawada, H; Tsuboya, N; Yodoya, N; Zhang, E | 1 |
| Guo, H; Hong, B; Jin, Z; Li, L; Zhang, J; Zhang, S; Zhi, H | 1 |
| Abdelaziz, RR; Elkashef, WF; Said, E | 1 |
| Katz, A | 1 |
| Kass, DA | 1 |
| Ferrini, MG; Gonzalez-Cadavid, N; Kovanecz, I; Rajfer, J; Rambhatla, A; Sanchez, S; Vernet, D | 1 |
2 review(s) available for tadalafil and Cirrhosis
| Article | Year |
|---|---|
Penile rehabilitation.
Topics: Alprostadil; Carbolines; Causality; Clinical Protocols; Erectile Dysfunction; Fibrosis; Humans; Male; Nurse's Role; Penile Prosthesis; Penis; Phosphodiesterase Inhibitors; Piperazines; Postoperative Care; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Time Factors; Vasodilator Agents | 2009 |
Cardiac role of cyclic-GMP hydrolyzing phosphodiesterase type 5: from experimental models to clinical trials.
Topics: Carbolines; Cardiomyopathy, Dilated; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 5; Fibrosis; Heart; Heart Failure; Humans; Hypertrophy; Myocardium; Phosphodiesterase 5 Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Transforming Growth Factor beta; TRPC Cation Channels; Ventricular Remodeling | 2012 |
4 other study(ies) available for tadalafil and Cirrhosis
| Article | Year |
|---|---|
CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
Topics: Animals; Bone Morphogenetic Protein Receptors, Type II; Clustered Regularly Interspaced Short Palindromic Repeats; Fibrosis; Humans; Hypertension, Pulmonary; Lung; Mice; Monocrotaline; Point Mutation; Pulmonary Arterial Hypertension; Pulmonary Artery; Rats; Tadalafil | 2022 |
Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Topics: Animals; Antibiotics, Antineoplastic; Atrophy; Carbolines; Cardiomyopathies; Cardiotonic Agents; Cyclic GMP; Disease Models, Animal; Doxorubicin; Fibrosis; Male; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; Phosphodiesterase 5 Inhibitors; Signal Transduction; Tadalafil; Ventricular Dysfunction, Left | 2013 |
Tadalafil reduces airway hyperactivity and protects against lung and respiratory airways dysfunction in a rat model of silicosis.
Topics: Animals; Anti-Inflammatory Agents; Blood Vessels; Bronchial Hyperreactivity; Fibrosis; Humans; L-Lactate Dehydrogenase; Lung; Male; Neovascularization, Physiologic; Oxidative Stress; Pneumonia; Rats; Rats, Sprague-Dawley; Silicosis; Tadalafil; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2016 |
Chronic daily tadalafil prevents the corporal fibrosis and veno-occlusive dysfunction that occurs after cavernosal nerve resection.
Topics: Animals; Blotting, Western; Carbolines; Denervation; Fibrosis; Impotence, Vasculogenic; Male; Muscle, Smooth; Penis; Phosphodiesterase Inhibitors; Prostatectomy; Rats; Rats, Sprague-Dawley; Tadalafil | 2008 |